Probuphine Approval History
- FDA approved: Yes (First approved May 26th, 2016)
- Brand name: Probuphine
- Generic name: buprenorphine
- Dosage form: Implant
- Company: Titan Pharmaceuticals, Inc.
- Treatment for: Opiate Dependence
Probuphine (buprenorphine) is an opioid partial agonist subdermal implant for the treatment of opioid dependence.
Development History and FDA Approval Process for Probuphine
| Date | Article |
|---|
| May 26, 2016 |  FDA Approves Probuphine (buprenorphine) Implant for Treatment of Opioid Dependence |
| Feb 19, 2016 | Titan Pharmaceuticals Announces Notification of FDA Action Date Extension for Probuphine |
| Jan 12, 2016 | Titan Pharmaceuticals And Braeburn Pharmaceuticals Announce FDA Advisory Committee Recommends Approval Of Probuphine |
| Sep 28, 2015 | Titan Pharmaceuticals Announces FDA's Acceptance of Resubmission of NDA for Probuphine |
| Jun 8, 2015 | Titan Pharmaceuticals Reports Positive Results from Phase 3 Study of Probuphine for Opioid Addiction |
| Jul 21, 2014 | Titan Pharmaceuticals Announces First Patient Enrollment In Clinical Study Of Probuphine for Opioid Dependence |
| May 1, 2013 | Titan Pharmaceuticals Receives Complete Response Letter From the FDA for Probuphine New Drug Application |
| Feb 27, 2013 | Titan Pharmaceuticals Announces Date of FDA Advisory Committee Review of Probuphine for the Treatment of Opioid Dependence |
| Oct 29, 2012 | Titan Pharmaceuticals Announces Submission of New Drug Application for Probuphine for the Treatment of Opioid Dependence |
| Oct 13, 2010 | Titan Pharmaceuticals Announces Journal of the American Medical Association Publication of Phase 3 Probuphine Data |
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.
